Margaret McLoughlin
Fortune : 728 $ au 30/06/2026
Fortune : 728 $ au 30/06/2026
Margaret A. McLoughlin worked as Executive Director-World Wide Business Development at Pfizer Inc. from 2014 to 2019.
Served as Independent Director at Quince Therapeutics, Inc. from 2015 to 2026.
Held director positions at BioAtla, Inc., 4D Molecular Therapeutics, Inc., Adapsyn Bioscience, Inc., and Herophilus, Inc. Worked as Associate Director at Yale University.
Completed undergraduate studies at the University of California, Irvine.
Earned a doctorate from the University of California, Santa Barbara.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 02/01/2026 | 40 ( 0,15 % ) | 728 $ | 30/06/2026 |
| Sociétés | Poste | Fin |
|---|---|---|
| QUINCE THERAPEUTICS, INC. | Directeur/Membre du Conseil | 30/01/2026 |
| PFIZER INC. | Corporate Officer/Principal | 01/05/2019 |
| 4D MOLECULAR THERAPEUTICS, INC. | Directeur/Membre du Conseil | 20/03/2019 |
Yale University
Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
| BIOATLA, INC. | Directeur/Membre du Conseil | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 9 |
|---|---|
Pfizer Inc.
Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Yale University
Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California, Irvine
University of California, Irvine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California, Santa Barbara
University of California, Santa Barbara Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BioAtla, Inc.
BioAtla, Inc. BiotechnologyHealth Technology Develops novel monoclonal antibody and protein therapeutic products | Health Technology |
4D Molecular Therapeutics, Inc.
4D Molecular Therapeutics, Inc. BiotechnologyHealth Technology Designs, develops and commercializes transformative gene therapeutic products for serious unmet medical conditions | Health Technology |
Quince Therapeutics, Inc.
Quince Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops drugs for the treatment of central nervous system disorders and Alzheimer’s diseases | Health Technology |
Adapsyn Bioscience, Inc.
Adapsyn Bioscience, Inc. BiotechnologyHealth Technology Operates as a biotechnology company focussed on the discovery and development of novel medicines | Health Technology |
Herophilus, Inc.
Herophilus, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops neurotherapeutics to cure complex brain diseases | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national